Top Markets
Coin of the day
I'rom Group Co., Ltd. I'rom Group Co., Ltd.

I'rom Group Co., Ltd.

2372
Rangering i aksjer #17926
I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key... I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key areas: pioneering advanced medical treatments, offering site management organization (SMO) services, acting as a contract research organization (CRO), and providing various forms of medical support. The company spearheads the creation of cutting-edge medical technologies, particularly in regenerative medicine and gene therapy, to combat conditions like obstructive arteriosclerosis, retinitis pigmentosa, and HIV/AIDS. Their innovative contributions include the Sendai virus vector and the CytoTune-iPS kit, designed for generating induced pluripotent stem cells. Furthermore, I'rom assists medical institutions with clinical trial execution and delivers extensive support for the development of novel drugs and medical equipment, with a focus on cancer, rare, and intractable diseases. The company also oversees the establishment and operation of clinic malls. Founded in Tokyo in 1997, it was formerly known as I'Rom Holdings Co., Ltd. until its name change in July 2015.
Aksjekurs
$18.20
Sist synkronisert: 2025-05-09
Markedsverdi
$220.35M
Endring (1 dag)
-5.34%
Endring (1 år)
0.00%
Land
JP
Handel I'rom Group Co., Ltd. (2372)

Kategori

Inntekter for I'rom Group Co., Ltd. (2372)
Inntekter i Dec 2024 TTM: $9.98M
Ifølge I'rom Group Co., Ltd. sine nyeste økonomiske rapporter er selskapets nåværende resultat $9.98M. I 2023 hadde selskapet et resultat på $25.17M, en økning sammenlignet med resultatet i 2022, som var $21.24M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for I'rom Group Co., Ltd. fra 2005 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $9.98M -23.16%
2024 $12.99M -48.39%
2023 $25.17M 18.51%
2022 $21.24M 39.44%
2021 $15.23M 45.30%
2020 $10.48M -1.23%
2019 $10.61M -38.18%
2018 $17.17M 595.33%
2017 $2.47M -134.25%
2016 $-7.21M 43.61%
2015 $-5.02M 55.00%
2014 $-3.24M -117.10%
2013 $18.94M -1,247.10%
2012 $-1.65M -227.92%
2011 $1.29M -117.79%
2010 $-7.26M -93.02%
2009 $-104.01M 912.86%
2008 $-10.27M 79.68%
2007 $-5.72M -184.52%
2006 $6.76M -56.10%
2005 $15.40M 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$9.87B 98,800.88%
US
- -
DE
$687.82M 6,791.50%
SA
$3.87B 38,624.74%
US
- -
MY